Trump Moves to Lower Drug Prices in Medicare Part D

On Monday, the Trump administration proposed a set of changes that have the potential to lower the prices of some pharmaceuticals paid for through Medicare Part D. As set out in the proposed rule, the plan has three major new provisions: providing Part D plans with more flexibility to manage protected classes, updating existing e-prescribing systems to make patients' costs visible when a prescription is ordered, and requiring pharmacy price concessions for drugs at the point of sale.